4//SEC Filing
Deardorf Caren 4
Accession 0000899243-22-006821
CIK 0001690585other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 5:20 PM ET
Size
5.5 KB
Accession
0000899243-22-006821
Insider Transaction Report
Form 4
Deardorf Caren
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-15+75,000→ 75,000 totalExercise: $3.19Exp: 2032-02-14→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is February 1, 2022.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001871152
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 5:20 PM ET
- Size
- 5.5 KB